22 related articles for article (PubMed ID: 17006259)
1. Proliferating cell nuclear antigen (PCNA), p53 and MDM2 expression in Hodgkins disease.
Pinheiro GS; Silva MR; Rodrigues CA; Kerbauy J; de Oliveira JS
Sao Paulo Med J; 2007 Mar; 125(2):77-84. PubMed ID: 17625704
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study.
Barisik NO; Bozkurt S; Gumus M; Kaygusuz I; Karadayi N; Bas E; Bayik M; Tecimer T
Diagn Pathol; 2010 Mar; 5():19. PubMed ID: 20346139
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.
Nagpal P; Akl MR; Ayoub NM; Tomiyama T; Cousins T; Tai B; Carroll N; Nyrenda T; Bhattacharyya P; Harris MB; Goy A; Pecora A; Suh KS
Oncotarget; 2016 Oct; 7(41):67551-67573. PubMed ID: 27563824
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin lymphoma: an update on its biology with new insights into classification.
Mani H; Jaffe ES
Clin Lymphoma Myeloma; 2009 Jun; 9(3):206-16. PubMed ID: 19525189
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of p53, bcl-2, and p21waf1 in 48 Argentinean children with non-Hodgkin lymphoma.
Chabay P; De Matteo E; Preciado M
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):12-7. PubMed ID: 16540724
[TBL] [Abstract][Full Text] [Related]
6. Oncogene expression in tumour cells of pediatric Hodgkin's disease in Argentina--correlation with Epstein Barr virus presence.
Preciado MV; Cristobal E; Menarguez J; Martinez Montero JC; Diez B; De Matteo E; Grinstein S
Pathol Res Pract; 1998; 194(1):25-31. PubMed ID: 9542744
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
[TBL] [Abstract][Full Text] [Related]
8. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
[TBL] [Abstract][Full Text] [Related]
9. p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.
Pescarmona E; Pignoloni P; Puopolo M; Martelli M; Addesso M; Guglielmi C; Baroni CD
J Pathol; 2001 Oct; 195(3):361-6. PubMed ID: 11673835
[TBL] [Abstract][Full Text] [Related]
10. No Influence of bcl-2, p53, and p21waf1 protein expression on the outcome of pediatric Hodgkin lymphomas.
Chabay P; Pesce P; De Matteo E; Lombardi MG; Rey G; Preciado MV
J Pediatr Hematol Oncol; 2006 Sep; 28(9):552-8. PubMed ID: 17006259
[TBL] [Abstract][Full Text] [Related]
11. Molecular control of the cell cycle in cancer: biological and clinical aspects.
Møller MB
Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
[TBL] [Abstract][Full Text] [Related]
12. A practical approach to the diagnosis of Hodgkin lymphoma.
Listinsky CM
Am J Clin Pathol; 2002 Jun; 117 Suppl():S76-94. PubMed ID: 14569804
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
